ScheBo - Biotech AG is an innovative biotechnology company active in the development, production and marketing of in-vitro diagnostics.
Numerous innovations, a pronounced customer orientation and creative problem solving have made ScheBo - Biotech AG a globally successful manufacturer of unique products.
ScheBo - Biotech AG was founded by the biochemists and molecular biologists Dr. Ursula Scheefers-Borchel and Dr. Hans Scheefers and we invite you to convince yourself of the advantages of ScheBo - Biotech AG.
Gastroenterology is a medical specialty that deals with diseases of the gastrointestinal tract, liver, and pancreas. Gastroenterologists diagnose and treat diseases such as stomach ulcers, inflammatory bowel diseases, liver cirrhosis and pancreatitis.
Oncology is a medical specialty that deals with the diagnosis, treatment, and prevention of cancers. Oncologists are experts in specific types of cancer and offer their patients individual, holistic care that includes both medical and emotional support.
Veterinary diagnostics refers to the examination and diagnosis of diseases and health conditions in animals. Veterinary diagnosticians use various laboratory tests, imaging techniques, and clinical investigations to help veterinarians identify diseases and develop an appropriate treatment plan.
SARS-CoV-2 diagnostics refers to the investigations and tests carried out to diagnose an infection with the SARS-CoV-2 virus that causes COVID-19. Diagnostics include tests such as PCR antigen and antibody tests to determine the presence of the virus or the development of immunity.
ScheBo - Biotech AG is internationally active and offers innovative products that have a unique position worldwide in the field of in-vitro diagnostics.
Continuous innovation, a pronounced customer orientation and creative problem solving have made ScheBo - Biotech AG a globally successful manufacturer of unique products.
If you are looking for innovative and unique products with high quality, you can rely on ScheBo - Biotech AG. You are welcome.